< Back to latest news & events

HGF Presents

Antibodies

September 2025

Video overview:

EPO Requirements for Antibody Applications

  • The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues.
  • Antibodies can be defined by various aspects, including but not limited to:
    (a) Their amino acid sequences (structure)
    (b) Nucleic acid sequences encoding the antibody
    (c) Reference to the target antigen
    (d) Target antigen plus additional functional features
    (e) Functional and structural characteristics
    (f) Production process
    (g) Hybridoma producing the antibody

Drafting Tips

  • Include claims with varying scope (broad to narrow) in the same application.
  • Cover both full antibodies and antibody fragments.
  • Use multiple claim categories (e.g., product, process, use).
  • Provide direct experimental evidence of the antibody’s technical effect at filing.
  • Carefully consider the order in which alternative antibodies are claimed.
  • Plan your filing strategy to allow for future related applications; be mindful of initial disclosures.

Latest updates

Regulatory Exclusivity for
Medicinal Products in Europe

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. No exclusivity granted for new formulations or routes of …

Read article

Added Matter - Part 2

Video overview: Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively Before grant, amendments can broaden the claim scope as long as the resulting claim is …

Read article

Added Matter - Part 1

Video overview: What is Added Matter? Added matter occurs when an amendment introduces content that goes beyond what was originally disclosed in the application as filed (Article 123(2) EPC). EPO …

Read article

Patenting Polymorphs at the EPO

Video overview: Novelty and Inventive Step Prior art must necessarily lead to the claimed polymorph to be novelty destroying Watch out for inherent disclosures in prior art—methods may implicitly produce …

Read article

Antibodies

Video overview: EPO Requirements for Antibody Applications The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues. Antibodies can be defined by various aspects, including but not …

Read article

Description Amendment Requirements at EPO

Video overview: At the final stage of prosecution, the EPO increasingly insists each patent description must align with the allowed claims to improve clarity and eliminate inconsistencies. However, this strict …

Read article

Computer-implemented Inventions

Video overview: To obtain a patent for a CII in Europe, two main hurdles must be cleared: Eligibility A claim must have technical character—even one technical feature is enough. Examples …

Read article

Bioinformatics at the EPO

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. …

Read article